Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Warby Parker Inc.NYSE: WRBY

Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026

Capital expenditures growth accelerates

Q2 FY2026 capital expenditures of $22.86M (cash outflow) rose 40.4% year over year, ahead of the +14.3% change in trailing-twelve-month capital expenditures. Sequentially, it rose 41.7% from the prior quarter. Over 3 fiscal years it compounded at +3.7% a year.

Context

  • Capital expenditures amounted to 7.7% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +40.4% holds above the trailing-twelve-month pace of +14.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$22.86M+41.7% QoQ
Last fiscal yearDec 2025
-$67.05M+4.7% YoY
LTMJun 2026
-$73.61M+14.3% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+40.4%——
1 year+4.7%——
3-year CAGR+3.7%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(67.05M) USD
Year-over-year change
-4.7%

Capital Expenditures vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 capital expenditures of $73.61M is the 6th largest of the 10 companies compared; the peer median is $81.8M.
  • Its year-over-year change of +14.3% is the 3rd highest of 10, against a peer median of +1.8%.
  • Capital expenditures amounts to 8.1% of revenue for WRBY, versus a peer median of 3.8%.
WRBY Competitors Peer median
Capital Expenditures for WRBY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BHCBausch Health Companies Inc.LTM Jun 2026$408.39M +1.8%+14.0%3.8%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$164M -0.6%-4.2%4.5%
ITGRInteger Holdings CorporationLTM Jul 2026$93.46M +4.3%+6.8%5.1%
ICUIICU Medical, Inc.LTM Jun 2026$83.54M +7.4%-3.9%3.9%
QDELQuidelOrtho CorporationLTM Mar 2026$81.8M -31.2%+10.1%3.1%
WRBYWarby Parker Inc.LTM Jun 2026$73.61M +14.3%+3.7%8.1%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$69.39M -12.0%+21.4%3.0%
HAEHaemonetics CorporationLTM Jun 2026$36.93M -1.2%-33.2%2.7%
BEAMBeam Therapeutics Inc.LTM Jun 2026$13.39M +24.6%-32.7%8.6%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$8.18M +17.3%+28.1%3.2%
Peer median (excluding WRBY) $81.8M+1.8%+6.8%3.8%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
Deferred Income Tax00000
Stock-Based Compensation107.15M98.03M70.51M47.29M34.54M
Change in Working Capital(24.5M)(14.55M)5.81M19.26M17.55M
Accounts Receivables(392K)(451K)(345K)(169K)(1.34M)
Inventory(18.62M)(11.79M)6.61M9.89M7.83M
Accounts Payables(11.11M)(7.94M)1.63M689K8.5M
Other Working Capital5.63M5.64M(2.09M)8.85M2.55M
Other Non-Cash Items7.76M5.42M9.32M6.72M6.78M
Operating Cash Flow(31.99M)10.37M60.99M98.74M110.79M
Capital Expenditures(48.51M)(60.18M)(53.67M)(64.03M)(67.05M)
Acquisitions (Net)00000
Purchases of Investments00(1M)(2M)0
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(48.51M)(60.18M)(54.67M)(66.03M)(67.05M)
Debt Repayment31.61M91K000
Common Stock Issued20.04M3.2M2.87M4.63M2.36M
Common Stock Repurchased(8.09M)0000
Dividends Paid00000
Other Financing Activities(20.56M)00333K(14.36M)
Financing Cash Flow23M3.29M2.87M4.96M(12M)
Effect of Forex Changes(161K)(1.31M)(882K)(406K)457K
Net Change in Cash(57.67M)(47.83M)8.31M37.27M32.2M
Free Cash Flow(80.51M)(49.81M)7.32M34.71M43.74M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.